English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Amicoumacin a inhibits translation by stabilizing mRNA interaction with the ribosome.

MPS-Authors
/persons/resource/persons15723

Rodnina,  M. V.
Department of Physical Biochemistry, MPI for biophysical chemistry, Max Planck Society;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)

2062475_Suppl_1.htm
(Supplementary material), 53KB

2062475_Suppl_2.htm
(Supplementary material), 53KB

2062475_Suppl_3.htm
(Supplementary material), 53KB

2062475_Suppl_4.htm
(Supplementary material), 53KB

Citation

Polikanov, Y. S., Osterman, I. A., Szal, T., Tashlitsky, V. N., Serebryakova, M. V., Kusochek, P., et al. (2014). Amicoumacin a inhibits translation by stabilizing mRNA interaction with the ribosome. Molecular Cell, 56(4), 531-540. doi:10.1016/j.molcel.2014.09.020.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0023-F410-A
Abstract
We demonstrate that the antibiotic amicoumacin A (AMI) is a potent inhibitor of protein synthesis. Resistance mutations in helix 24 of the 16S rRNA mapped the AMI binding site to the small ribosomal subunit. The crystal structure of bacterial ribosome in complex with AMI solved at 2.4 Å resolution revealed that the antibiotic makes contacts with universally conserved nucleotides of 16S rRNA in the E site and the mRNA backbone. Simultaneous interactions of AMI with 16S rRNA and mRNA and the in vivo experimental evidence suggest that it may inhibit the progression of the ribosome along mRNA. Consistent with this proposal, binding of AMI interferes with translocation in vitro. The inhibitory action of AMI can be partly compensated by mutations in the translation elongation factor G.